The impact of activity‐based protein profiling in malaria drug discovery

HIGHLIGHTS

• who: from the Luis Carvalho completed his PhD in Pharmacy in , from the Faculty of Pharmacy of the University of LisbonLuis became interested in Proteomics and Activity-based Protein Profiling (ABPP) during a Fulbright-sponsored stay at the Cravatt Lab in The Scripps Research Institute in, . Luis is currently a Marie Sklodowska-Curie Fellow in the Bernardes Group in the University of Cambridge, where he is developing ABPP platforms and PROTACs for biological applications. Gonu00e7alo Bernardes completed his D.Phil. in , at the University of Oxford, U.K. He undertook postdoctoral work at the MaxPlanck Institute of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.